Cancer
Nasopharyngeal carcinoma in Zhanjiang
湛江 鼻咽癌
2 hospitals in Zhanjiang
Order: papers led on nasopharyngeal carcinoma, 2021–2025, then A–Z. Research activity, not a rating of care.
Only hospitals listed for nasopharyngeal carcinoma: those with enough papers or registered trials on it in the records this site uses. Other hospitals in Zhanjiang may also treat it. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first.
- 18 papers led
- 0 papers ledNo open trial led
Nasopharyngeal carcinoma in every city Zhanjiang on the disease page, with the national map
open trials on nasopharyngeal carcinoma with a hospital in Zhanjiang
Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 8 Nov 2026, with a listed hospital in Zhanjiang as lead sponsor or study site. 2 of them are led by a hospital in Zhanjiang. Check the registry for the current status. Whether someone can take part is decided by the study team.
Only trials registered on ClinicalTrials.gov are counted. Trials registered only in China’s own registry (ChiCTR) are not.
- RecruitingToripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma
- Phase
- Phase 2
- Started
- 2026-03
- Registry
- NCT07362979
Age 18 years to 70 years (registered criteria)
Led by Sun Yat-sen University Cancer Center; 3 listed hospitals as study sitesDongguan, Guangzhou, Shenzhen, Zhanjiang
- RecruitingToripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma
- Phase
- Phase 2
- Started
- 2025-07
- Registry
- NCT07136519
Age 18 years to 65 years (registered criteria)
Led by Affiliated Hospital of Guangdong Medical UniversityZhanjiang
- RecruitingReduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response
- Phase
- Phase 3
- Started
- 2024-03
- Registry
- NCT06239727
Age 18 years to 65 years (registered criteria)
Led by Sun Yat-sen University Cancer Center; 21 listed hospitals as study sitesChangsha, Chengdu, Chongqing, Dongguan, Foshan, Fuzhou, Guangzhou, Guiyang, Haikou, Hangzhou, Nanchang, Nanjing, Nanning, Shantou, Tianjin, Wuhan, Xi'an, Xiamen, Zhanjiang
- RecruitingSapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma
- Phase
- Phase 3
- Started
- 2022-08
- Registry
- NCT07327216
Age 18 years to 75 years (registered criteria)
Led by Affiliated Hospital of Guangdong Medical UniversityZhanjiang
- Not yet recruitingShrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity
- Phase
- Phase 3
- Started
- 2025-08
- Registry
- NCT07072000
Age 18 years to 70 years (registered criteria)
Lead sponsor is not a listed hospital; 5 listed hospitals as study sitesFoshan, Guangzhou, Liuzhou, Wuzhou, Zhanjiang
Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.
Disease research in Zhanjiang
Each number is papers led on that disease, 2021–2025. “Open” counts open trials the hospital leads. Hospitals A–Z; this is not a ranking.
A blank cell means no papers or trials were found in these records. It does not mean the hospital does not treat that disease.
| Cancer | Blood disorders | Other diseases | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital | Nasopharyngeal carcinoma | Oesophageal squamous cell carcinoma | Hepatocellular carcinoma | Stomach cancer | Hepatoblastoma | Retinoblastoma | Chordoma | Osteosarcoma | Gastrointestinal stromal tumour | Neuroblastoma | Ewing sarcoma | Multiple myeloma | B-cell acute lymphoblastic leukaemia | Aplastic anaemia | Haemophagocytic lymphohistiocytosis | Beta thalassaemia | Haemophilia A | Atypical haemolytic uraemic syndrome | Thrombotic thrombocytopenic purpura | Fanconi anaemia | Neuromyelitis optica spectrum disorder | IgG4-related disease | Myasthenia gravis | Moyamoya disease | Wilson disease | Biliary atresia | Anti-NMDA receptor encephalitis | Takayasu arteritis | Hepatic echinococcosis | Idiopathic pulmonary fibrosis | Lymphangioleiomyomatosis | Amyotrophic lateral sclerosis | Spinal muscular atrophy | Fabry disease | Pompe disease | Duchenne muscular dystrophy | Behçet disease | Alport syndrome | IgA nephropathy | Gaucher disease | Niemann–Pick disease type C | Osteogenesis imperfecta | Primary biliary cholangitis | Primary sclerosing cholangitis | Congenital diaphragmatic hernia | Hirschsprung disease | Inherited epidermolysis bullosa | Hereditary angioedema | Familial adenomatous polyposis | Leber hereditary optic neuropathy | Majeed syndrome | NGLY1 deficiency | ISG15 deficiency | Shortlist |
| Affiliated Hospital of Guangdong Medical University广东医科大学附属医院 | 182 open | 3 | 211 open | none | none | 1 | none | 7 | 0 | 1 | none | 3 | 01 open | none | none | 1 | 1 | none | none | none | none | none | none | none | none | none | 1 | none | none | 1 | none | none | none | none | none | none | none | none | 2 | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | |
| First Navy Hospital中国人民解放军南部战区海军第一医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Guangdong Medical University Affiliated Second Hospital广东医科大学附属第二医院 | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Zhanjiang Central Hospital湛江中心人民医院 | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
Column labels are short names. Choose one to open that disease in Zhanjiang.
- Nasopharyngeal carcinoma 182 open
- Oesophageal squamous cell carcinoma 3
- Hepatocellular carcinoma 211 open
- Retinoblastoma 1
- Osteosarcoma 7
- Gastrointestinal stromal tumour 0
- Neuroblastoma 1
- Multiple myeloma 3
- B-cell acute lymphoblastic leukaemia 01 open
- Beta thalassaemia 1
- Haemophilia A 1
- Anti-NMDA receptor encephalitis 1
- Idiopathic pulmonary fibrosis 1
- IgA nephropathy 2
- Primary biliary cholangitis 0
Other cities nearby
Straight-line distance from the city centre; counts are hospitals listed for nasopharyngeal carcinoma.
Counts are listed hospitals only, not every hospital in each city.
- 76 kmMaoming茂名None listed for nasopharyngeal carcinoma
- 134 kmHaikou海口2 hospitals for nasopharyngeal carcinoma
- 272 kmWuzhou梧州1 hospital for nasopharyngeal carcinoma
- 280 kmNanning南宁5 hospitals for nasopharyngeal carcinoma
- 299 kmZhaoqing肇庆None listed for nasopharyngeal carcinoma
- 319 kmJiangmen江门1 hospital for nasopharyngeal carcinoma
Where these numbers come from
Papers
English-language PubMed papers, 2021–2025, where the first or last author lists the hospital first. Definitions
Trials
ClinicalTrials.gov records with the hospital as lead sponsor or site, as of 8 Nov 2026. Search Zhanjiang on ClinicalTrials.gov
Locations
Locations are shown at city centres. Check the hospital’s website for its address.